Cost of translating consent documents may serve as a barrier to participation of members of underrepresented groups in clinical trials

UCLA Jonsson Comprehensive Cancer Center researchers say that relieving investigators of consent document translation costs could make studies more inclusive and results more accurate and generalizable
patient consent
New study published in Nature suggests that the cost of consent document translation in trials not sponsored by industry could be a potentially modifiable barrier to the inclusion of patients with limited English proficiency.